Literature DB >> 4565851

Proteolytic activity of Cryptococcus neoformans against human plasma proteins.

H E Müller, K K Sethi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4565851     DOI: 10.1007/bf02120478

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  16 in total

1.  CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.

Authors:  J E BENNETT; H F HASENCLEVER
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

2.  [Cultural, biochemical & serological behavior of the Cryptococcus group].

Authors:  H P SEELIGER
Journal:  Ergeb Mikrobiol Immunitatsforsch Exp Ther       Date:  1959

3.  Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.

Authors:  M L LITTMAN; E TSUBURA
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

4.  The pulmonary lesions in cryptococcosis with special reference to subpleural nodules.

Authors:  R K HAUGEN; R D BAKER
Journal:  Am J Clin Pathol       Date:  1954-12       Impact factor: 2.493

5.  [Capsular polyoside of a pathogenic fungus Torulopsis neoformans; relation to virulence].

Authors:  E DROUHET; G SEGRETAIN; J P AUBERT
Journal:  Ann Inst Pasteur (Paris)       Date:  1950-12

6.  [Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans].

Authors:  E DROUHET; G SEGRETAIN
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-12

7.  [Immunelectrophoretic studies in the action of bacterial enzymes on human plasma proteins].

Authors:  H E Müller
Journal:  Zentralbl Bakteriol Orig A       Date:  1971-06

8.  Serum-proteins as nitrogen source for yeastlike fungi.

Authors:  F Staib
Journal:  Sabouraudia       Date:  1965-10

9.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

View more
  7 in total

1.  Purification and characterization of a 43-kilodalton extracellular serine proteinase from Cryptococcus neoformans.

Authors:  Jae il Yoo Ji; Yeong Seon Lee; Chul-Yong Song; Bong Su Kim
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Proteolytic action of Legionella pneumophila on human serum proteins.

Authors:  H E Müller
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

3.  Proteolytic activity of a clinical isolate of Cryptococcus neoformans.

Authors:  C H Brueske
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Cutaneous cryptococcosis in athymic and beige-athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

5.  Extracellular proteolytic activity of Cryptococcus neoformans.

Authors:  S Aoki; S Ito-Kuwa; K Nakamura; J Kato; K Ninomiya; V Vidotto
Journal:  Mycopathologia       Date:  1994-12       Impact factor: 2.574

Review 6.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

7.  Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America.

Authors:  Ashwin Dixit; Scott F Carroll; Salman T Qureshi
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.